Bethany L. Mundy-Bosse
Immunology and Microbiology · The Ohio State University
Publications
139
Citations
4,057
Est. group size
~18
Recurring co-author estimate
Active years
25
Publishing since 2001
Bethany L. Mundy-Bosse studies immune cells, particularly natural killer (NK) cells and other innate lymphoid cells, and how they function in blood cancers such as acute myeloid leukemia and in solid tumors like endometrial cancer. Her work combines cellular and molecular analysis of the tumor microenvironment and bone marrow niche to understand how immune cells can either fight or fail to control cancer. This research is relevant to students interested in tumor immunology, hematologic malignancies, and immune cell development.
Publication output was relatively steady but modest through 2017-2022, then spiked sharply in 2023 before settling back to a more moderate but still elevated pace in 2024-2025.
Generated by claude-sonnet-5 from public bibliographic data · Jul 20, 2026
- Abstract 5261: The significance of CD200R1 on NK cells in the endometrial cancer tumor microenvironment
Cancer Research · 2025
- Multiomic profiling identifies predictors of survival in African American patients with acute myeloid leukemia
Nature Genetics · 2024
- Cellular taxonomy of the preleukemic bone marrow niche of acute myeloid leukemia
Leukemia · 2024
- Abstract P07: Identification of the unique preleukemic bone marrow niche in acute myeloid leukemia
Blood Cancer Discovery · 2024
- 3079 – CANCER-ASSOCIATED FIBROBLASTS (CAFS) AND THE PRELEUKEMIC BONE MARROW NICHE
Experimental Hematology · 2024
- Early exposure to exogenous IL-15 subverts ILC precursor priming and the generation of KIR+ NK cells
The Journal of Immunology · 2024
- Natural killer cells display unique, non-cytotoxic profiles in human endometrial cancer
The Journal of Immunology · 2024
- Targeting PRMT5-Mediated DNA Repair Pathway in Extra-Nodal NK/T-Cell Lymphoma (ENKTL)
Blood · 2024
- Single-cell RNA sequencing identifies a population of human liver-type ILC1s
Cell Reports · 2023
- Human endometrial cancers contain two distinct subsets of natural killer cells (2269)
Gynecologic Oncology · 2023
- Deletion of Glycogen Synthase Kinase 3 Beta Reprograms NK Cell Metabolism
Cancers · 2023
- Mapping human natural killer cell development in pediatric tonsil by imaging mass cytometry and high-resolution microscopy
bioRxiv (Cold Spring Harbor Laboratory) · 2023
- A Randomized Double-Blind Placebo-Controlled Phase II Multi-Center Study of Inflammation Modification of Canakinumab to Prevent Leukemic Progression of Clonal Cytopenias of Unknown Significance (CCUS): Impact Study
Blood · 2023
- Abstract 1351: Uterine natural killer cells display a unique functional dichotomy in human endometrial cancer
Cancer Research · 2023
- Cellular taxonomy of the preleukemic bone marrow niche of acute myeloid leukemia
bioRxiv (Cold Spring Harbor Laboratory) · 2023
- Blood×15
- The Journal of Immunology×9
- Cancer Research×6
- Immunity×3
- Journal of Clinical Investigation×3
- William E. Carson
Immunology and Microbiology · The Ohio State University
- Lukman O. Afolabi
Immunology and Microbiology · Indiana University
- Aharon G. Freud
Immunology and Microbiology · The Ohio State University
- Ankita Saini
Immunology and Microbiology · The Ohio State University
- Matthew McCullen
Immunology and Microbiology · The Ohio State University
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Jul 19, 2026.
Claim or correct this profile